ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

MRK Merck and Co Inc

125,02
-0,83 (-0,66%)
Nach Börsenschluss
Zuletzt aktualisiert: 01:38:47
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Merck and Co Inc MRK NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
-0,83 -0,66% 125,02 01:38:47
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
126,84 125,05 128,73 125,26 125,85
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
26.7.202412:50BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
23.7.202418:52BWMerck Announces Fourth-Quarter 2024 Dividend
23.7.202412:45BWMerck Announces Topline Results from Phase 2b/3 Trial of..
16.7.202412:45BWMerck to Share New Research and Host Community-Focused..
12.7.202412:45BWMerck Completes Acquisition of EyeBio
09.7.202414:30BWMerck Animal Health Completes Acquisition of Elanco’s Aqua..
09.7.202414:28PRNUSElanco Completes Sale of Aqua Business
01.7.202414:15BWMerck and Orion Announce Mutual Exercise of Option Providing..
01.7.202412:45BWMerck to Hold Second-Quarter 2024 Sales and Earnings..
28.6.202412:53BWMerck Receives Positive EU CHMP Opinion for WINREVAIR™..
28.6.202402:18BWCDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™..
27.6.202413:13IHMARKETNEWSInteractive Brokers Loses $48 Million on NYSE, Amazon..
27.6.202401:45BWPatritumab Deruxtecan BLA Submission Receives Complete..
25.6.202422:05BWUSDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu..
18.6.202413:02IHMARKETNEWSFisker Files for Bankruptcy, Chegg Stocks Rise on 23%..
17.6.202423:29BWU.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent..
17.6.202423:15BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus..
05.6.202412:45BWMerck to Participate in the Goldman Sachs 45th Annual Global..
04.6.202421:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202420:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202420:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202420:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202420:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202420:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202420:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202415:10IHMARKETNEWSEconomic Worries May Lead To Weakness On Wall Street
30.5.202422:39EDGAR2Form CERT - Certification by an exchange approving..
30.5.202422:28EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
30.5.202422:14EDGAR2Form 8-K - Current report
29.5.202415:10IHMARKETNEWSRising Treasury Yields May Weigh On Wall Street
29.5.202413:34IHMARKETNEWSRobinhood Shares Surge 3.3% on Stock Buyback Announcement;..
29.5.202413:15BWFDA Grants Priority Review to Merck’s Application for..
29.5.202412:45BWMerck to Acquire EyeBio
28.5.202422:44IHMARKETNEWSNasdaq Climbs To Another Record Closing High But Dow Sees..
28.5.202422:31EDGAR2Form SD - Specialized disclosure report
28.5.202421:12BWMerck Announces Third-Quarter 2024 Dividend
28.5.202412:45BWMerck Announces Phase 3 KEYNOTE-522 Trial Met its Overall..
20.5.202412:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16.5.202422:15EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
15.5.202417:31EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
15.5.202412:45BWMerck to Present New Data at 2024 ASCO Annual Meeting..
13.5.202412:45BWMerck Provides Update on Phase 3 KeyVibe-010 Trial..
09.5.202413:05PRNCASanté Canada approuve KEYTRUDA® pour le traitement, en..
09.5.202412:45BWMerck Provides Update on Phase 3 KEYNOTE-B21 Trial..
08.5.202412:45BWMerck to Participate in the Bank of America Securities 2024..
06.5.202422:29EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

Delayed Upgrade Clock